CPhA calls for stronger oversight of PBM practices, encouraged by Competition Bureau guidance
November 16, 2026 (Ottawa): The Canadian Pharmacists Association (CPhA) is calling for stronger oversight of insurer and pharmacy benefit manager (PBM) practices following the Competition Bureau’s investigation into Express Scripts Canada, including service fees, audit practices and patient steering.
While disappointed that the Bureau found insufficient evidence to take enforcement action at this time, CPhA is encouraged by its guidance identifying circumstances in which pharmacy network arrangements may raise competition concerns. The guidance provides a foundation for action, alongside broader concerns about PBMs’ bargaining power and the conditions they impose on pharmacies.
The Bureau identifies potential competition risks associated with vertical integration, closed or mandatory networks, unequal reimbursement or administrative terms, and the cumulative impact of multiple networks. The Bureau also stated that it will not hesitate to take appropriate enforcement action if new information emerges suggesting that a preferred provider network (PPN) may raise issues under the Competition Act.
The Bureau found that Express Scripts Canada's closed or mandatory networks are not widely used in Canada and that relatively few prescriptions have been diverted to pharmacies owned by Express Scripts Canada. Canada has an opportunity to establish safeguards before potentially restrictive arrangements become more widespread, informed by this guidance and lessons from the United States.
Concerns about service fees and audits extend beyond whether a PBM owns a competing pharmacy. Insurers and plan sponsors can influence network design and plan requirements, while PBMs may administer claims, apply fees and conduct audits. Pharmacies may have little practical choice but to accept these terms and conditions to process insurance claims for their patients. Fees, administrative requirements and audit demands can place additional pressure on pharmacy sustainability and divert staff time away from patient care. These concerns warrant attention whether or not a practice meets the threshold for competition enforcement.
CPhA is calling on federal, provincial and territorial governments to examine gaps in the existing framework and establish enforceable protections that:
- Preserve patient choice, fair network access and clinical independence to make decisions based on patients’ needs.
- Establish transparent and reasonable standards for insurer and PBM fees, contract conditions and administrative requirements, minimizing unnecessary demands on pharmacists’ time so they can focus on patient care.
- Ensure proportionate audits and fair, independent dispute resolution.
CPhA will work with provincial pharmacy association partners to document the impact of insurer and PBM practices and advance concrete proposals for policy and legislative reform. It will also engage insurers, PBMs and other health-system partners on practical solutions that support patient choice, fair treatment of pharmacies and greater accountability.
The Bureau’s guidance creates an opportunity to move forward. Governments and the sector should use it to strengthen protections for pharmacies and the patients they serve.
About the Canadian Pharmacists Association
The Canadian Pharmacists Association (CPhA) is the uniting national voice of pharmacy and the pharmacist profession in Canada. As pharmacists undertake an enhanced role in the delivery of health care services, CPhA ensures that the profession is recognized as a national leader in health care, influencing the policies, programs, budgets and initiatives affecting the profession and the health of Canadians.
For more information, please contact:
Tyler Gogo
Senior Manager, Communications
Canadian Pharmacists Association
tgogo@pharmacists.ca
613-293-7223
